NCT04688931 2024-06-06
ATLAS
UroGen Pharma Ltd.
Phase 3 Terminated
UroGen Pharma Ltd.
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Michigan Rogel Cancer Center
Memorial Sloan Kettering Cancer Center